Bosh sahifaAFX • FRA
add
Carl Zeiss Meditec AG
Yopilish kursi
46,86 €
Kunlik diapazon
46,68 € - 47,62 €
Yillik diapazon
45,02 € - 123,00 €
Bozor kapitalizatsiyasi
4,18 mlrd EUR
Oʻrtacha hajm
722,00
Narx/foyda
23,31
Dividend daromadliligi
-
Asosiy maydon
ETR
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 579,63 mln | -0,01% |
Joriy xarajat | 266,12 mln | 12,28% |
Sof foyda | 60,73 mln | -28,72% |
Sof foyda marjasi | 10,48 | -28,71% |
Har bir ulushga tushum | 1,01 | -0,48% |
EBITDA | 33,42 mln | -69,25% |
Amaldagi soliq stavkasi | 9,50% | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 20,28 mln | 91,35% |
Jami aktivlari | 3,39 mlrd | 11,88% |
Jami passivlari | 1,34 mlrd | 55,43% |
Umumiy kapital | 2,06 mlrd | — |
Tarqatilgan aksiyalar | 87,54 mln | — |
Narxi/balansdagi bahosi | 2,01 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 2,47% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 60,73 mln | -28,72% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Carl Zeiss Meditec AG is a multinational medical technology company and subsidiary of Carl Zeiss AG. It manufactures tools for eye examinations and medical lasers as well as solutions for neurosurgery, dentistry, gynecology and oncology. Among its products are the most common tools used by ophthalmologists and optometrists.
In October 2018, Carl Zeiss Meditec won FDA premarket approval for its ReLEx Smile laser system.
Also in October 2018, Carl Zeiss Meditec announced the acquisition of Reno, Nevada-based IanTech for an undisclosed sum.
In September 2019, Carl Zeiss Meditec launched the CIRRUS 6000 at the European Society of Retina Specialists 2019 Congress. Wikipedia
CEO
Tashkil etilgan
2002
Bosh ofis
Xodimlar soni
5 730
